Glutathione‐dependent reductive stress triggers mitochondrial oxidation and cytotoxicity

  • Huali Zhang
    Laboratory of Cardiac Disease, Redox Signaling, and Cell Regeneration Division of Cardiology University of Utah School of Medicine Salt Lake City Utah USA
  • Pattraranee Limphong
    Laboratory of Cardiac Disease, Redox Signaling, and Cell Regeneration Division of Cardiology University of Utah School of Medicine Salt Lake City Utah USA
  • Joel Pieper
    Laboratory of Cardiac Disease, Redox Signaling, and Cell Regeneration Division of Cardiology University of Utah School of Medicine Salt Lake City Utah USA
  • Qiang Liu
    Laboratory of Cardiac Disease, Redox Signaling, and Cell Regeneration Division of Cardiology University of Utah School of Medicine Salt Lake City Utah USA
  • Christopher K. Rodesch
    Cell Imaging Laboratory University of Utah School of Medicine Salt Lake City Utah USA
  • Elisabeth Christians
    Laboratory of Cardiac Disease, Redox Signaling, and Cell Regeneration Division of Cardiology University of Utah School of Medicine Salt Lake City Utah USA
  • Ivor J. Benjamin
    Laboratory of Cardiac Disease, Redox Signaling, and Cell Regeneration Division of Cardiology University of Utah School of Medicine Salt Lake City Utah USA

書誌事項

公開日
2011-12-27
権利情報
  • http://onlinelibrary.wiley.com/termsAndConditions#vor
DOI
  • 10.1096/fj.11-199869
公開者
Wiley

この論文をさがす

説明

<jats:p> To investigate the effects of the predominant nonprotein thiol, glutathione (GSH), on redox homeostasis, we employed complementary pharmacological and genetic strategies to determine the consequences of both loss‐ and gain‐of‐function GSH content <jats:italic>in vitro</jats:italic> . We monitored the redox events in the cytosol and mitochondria using reduction‐oxidation sensitive green fluorescent protein (roGFP) probes and the level of reduced/oxidized thioredoxins (Trxs). Either H <jats:sub>2</jats:sub> O <jats:sub>2</jats:sub> or the Trx reductase inhibitor 1‐chloro‐2,4‐dinitrobenzene (DNCB), in embryonic rat heart (H9c2) cells, evoked 8 or 50 mV more oxidizing glutathione redox potential, <jats:italic>E</jats:italic> <jats:sub>hc</jats:sub> (GSSG/2GSH), respectively. In contrast, <jats:italic>N</jats:italic> ‐acetyl‐L‐cysteine (NAC) treatment in H9c2 cells, or overexpression of either the glutamate cysteine ligase (GCL) catalytic subunit (GCLC) or GCL modifier subunit (GCLM) in human embryonic kidney 293 T (HEK293T) cells, led to 3‐ to 4‐fold increase of GSH and caused 7 or 12 mV more reducing <jats:italic>E</jats:italic> <jats:sub>hc</jats:sub> , respectively. This condition paradoxically increased the level of mitochondrial oxidation, as demonstrated by redox shifts in mitochondrial roGFP and Trx2. Lastly, either NAC treatment (EC <jats:sub>50</jats:sub> 4 mM) or either GCLC or GCLM overexpression exhibited increased cytotoxicity and the susceptibility to the more reducing milieu was achieved at decreased levels of ROS. Taken together, our findings reveal a novel mechanism by which GSH‐dependent reductive stress triggers mitochondrial oxidation and cytotoxicity.—Zhang, H., Limphong, P., Pieper, J., Liu, Q., Rodesch, C. K., Christians, E., Benjamin, I. J. Glutathione‐dependent reductive stress triggers mitochondrial oxidation and cytotoxicity. <jats:italic>FASEB J.</jats:italic> 26, 1442–1451 (2012). <jats:ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.fasebj.org">www.fasebj.org</jats:ext-link> </jats:p>

収録刊行物

被引用文献 (1)*注記

もっと見る

問題の指摘

ページトップへ